ETD Collection

Permanent URI for this collectionhttps://wiredspace.wits.ac.za/handle/10539/104


Please note: Digitised content is made available at the best possible quality range, taking into consideration file size and the condition of the original item. These restrictions may sometimes affect the quality of the final published item. For queries regarding content of ETD collection please contact IR specialists by email : IR specialists or Tel : 011 717 4652 / 1954

Follow the link below for important information about Electronic Theses and Dissertations (ETD)

Library Guide about ETD

Browse

Filters

20171

Settings

Author: search.filters.author.Lembede, Busisani WisemanSubject: search.filters.subject.Animal behavior

Search Results

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Item
    Effects of S-ALLYL-L-cysteine on high-fructose diet-induced neonatal metabolic programming in wistar rats
    (2017) Lembede, Busisani Wiseman
    The consumption of fructose during the perinatal period programmes for increased susceptibility to developing metabolic derangements immediately in childhood or later in adulthood. S-allyl-cysteine (SAC), a phytochemical constituent of garlic, has antioxidant, antidiabetic and antihyperlipidaemic properties. We hypothesised that neonatal orally administered SAC could protect against the development of high-fructose diet-induced metabolic derangements in both early and adult life. The study was undertaken in two major experiments. In the first experiment, the potential of neonatal oral administration of SAC to protect against acute metabolic derangements induced by high-fructose diet consumption in early-life was investigated. Sixty-four suckling (male = 32; female = 32) 4-day old Wistar rat pups were randomly allocated to and administered the following treatment regimens daily for 15 days: group I - 10 ml/kg distilled water (DH), group II - 10 ml/kg 20% fructose solution (FS), group III - 150 mg/kg body mass per day SAC, and group IV - (SAC + FS). On postnatal day 21 the pups’ blood cholesterol, glucose and triglyceride concentrations were determined. Immediately thereafter the pups were euthanised and tissues collected for analyses. Neonatal orally administered SAC significantly increased (p < 0.05) the plasma insulin concentration in male pups. The oral administration of a 20% FS decreased (p < 0.05) plasma insulin in the female pups. However, the anti-insulinotropic effect of a 20% FS in female rat pups was attenuated by orally administered SAC. Neonatal orally administered SAC showed insulinotropic effects in male rat pups and protected female rat pups against the anti-insulinotropic effect of a 20% FS. The second experiment investigated the potential of neonatal orally administered SAC to protect against high-fructose diet-induced metabolic derangements later in adulthood. One hundred and twenty-eight (males = 64; females = 64), 4-day old Wistar rat pups were randomly allocated to and administered treatment regimens as described for the first experiment. On postnatal day 21, the pups were weaned and allowed to grow on a standard rat chow (SRC) until postnatal day 56. The rats from each treatment regimen were then randomly split into two subgroups: one on a standard rat chow (SRC) and plain drinking water and another on SRC and 20% fructose drinking water and then subjected to these treatment regimens for eight weeks after which they were then euthanised and tissues collected for analyses. Neonatal orally administered 20% FS alone, programmed male and female rats to have increased (p < 0.05) liver lipid accretion in adulthood. The neonatal oral administration of SAC attenuated the programming of increased liver lipid accretion in adulthood induced by neonatal orally administered 20% FS. Thus neonatal oral administration of SAC could potentially protect against neonatal fructose consumption programming of fatty-liver related metabolic dysfunctions in adult life.